Join us on November 14th to help fight barriers to treatment access
The Schizophrenia & Psychosis Action Alliance is concerned about unfair developments on the horizon that could block access to a potential new treatment for schizophrenia. We need your help to speak out and spread the word.
Karuna Therapeutics has developed a new medication for schizophrenia called KarXT, which works in a different way than current treatments. They recently filed a New Drug Application with the U.S. Food and Drug Administration, which means that this medication may be a new treatment option in the future. Meanwhile, an organization called ICER (the Institute for Clinical and Economic Review) is reviewing the treatment (KarXT) to determine its “value.” ICER weighs the potential benefits of treatments against their potential cost, and its reviews are often used by insurance companies to determine how (and if) a treatment is covered by insurance.
We are deeply concerned that ICER’s review of KarXT is being conducted far too soon and will not include all of the information needed to make a fair decision. Without these critical data, ICER could make a recommendation against the drug that would prevent many people with schizophrenia from accessing it.
Here is what you can do to help:
Register for the free webinar on Tuesday, Nov. 14 (Noon-1 pm ET) that we are co-sponsoring with the Alliance for Patient Access to learn more about ICER, our concerns and what you can do.
Share the webinar link with others (family members, friends with lived experience, healthcare providers etc.) and encourage them to register.
Next month, we’ll share info about how you can send a letter to ICER to show your concern and share your personal experiences.
People with schizophrenia already face enormous barriers to getting the care they need and deserve. Enough is enough – please join us to learn more!